null
ChEBI ID: 27242
Member | Definition | Role |
---|---|---|
3-(3-amino-3-carboxypropyl)uridine | A derivative of uridine, bearing an additional 3-amino-3-carboxypropyl substituent at position 5 on the uracil ring. | 3-(3-amino-3-carboxypropyl)uridine |
5-bromouridine | A uridine having a bromo substituent at the 5-position. | 5-bromouridine |
5-carbamoylmethyluridine | A member of the class of uridines that is uridine in which the hydrogen at position 5 of the pyrimidine ring is substituted by a 2-amino-2-oxoethyl group. | 5-carbamoylmethyluridine |
5-fluorouridine | An organofluorine compound that is uridine bearing a fluoro substituent at position 5 on the uracil ring. | 5-fluorouridine |
5-hydroxyuridine | A member of the class of uridines that is uridine in which the hydrogen at position 5 of the uracil ring is substituted by a hydroxy group. | 5-hydroxyuridine |
5-methoxycarbonylmethyluridine | A derivative of uridine, bearing an additional methoxycarbonylmethyl substituent at position 5 on the uracil ring. | 5-methoxycarbonylmethyluridine |
5-methoxyuridine | A derivative of uridine, bearing an additional methoxy substituent at position 5 on the uracil ring. | 5-methoxyuridine |
5-methylaminomethyluridine | A derivative of uridine, bearing an additional methylaminomethyl substituent at position 5 on the uracil ring. | 5-methylaminomethyluridine |
5,6-dihydrouridine | The uridine derivative obtained by formal hydrogenation of the endocyclic double bond in the uracil ring. | dihydrouridine |
orotidine | A nucleoside formed by attaching orotic acid to a ribose ring via a beta-N(1)-glycosidic bond. | orotidine |
pn 401 | An acetate ester that is uracil in which the three hydroxy hydrogens are replaced by acetate group. A prodrug for uridine, it is used for the treatment of hereditary orotic aciduria and for management of fluorouracil toxicity. | uridine triacetate |
uridine | A ribonucleoside composed of a molecule of uracil attached to a ribofuranose moiety via a beta-N(1)-glycosidic bond. | uridine |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 9,077 (73.89) | 18.7374 |
1990's | 978 (7.96) | 18.2507 |
2000's | 1,041 (8.47) | 29.6817 |
2010's | 878 (7.15) | 24.3611 |
2020's | 310 (2.52) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 80 (0.60%) | 5.53% |
Reviews | 283 (2.13%) | 6.00% |
Case Studies | 64 (0.48%) | 4.05% |
Observational | 1 (0.01%) | 0.25% |
Other | 12,828 (96.77%) | 84.16% |